Company intelligence / Profile preview
Guangzhou Baiyunshan Qixing Pharmaceutical
- Ownership
- Private
- Development stage
- Other
Overview
Guangzhou Baiyunshan Qixing Pharmaceutical specializes in the development and production of traditional Chinese medicines and modern pharmaceuticals. It has a strong focus on cardiovascular/cerebrovascular drugs, pediatric medicines, and has nearly eighty product varieties. Several products are included in China's national medical insurance catalogue. Its flagship product "Huajing Zaizao Pill" won national science awards for stroke treatment. The company also develops small molecule antibiotics with several approved drugs for infectious disease.
- Therapeutic areas
- Infectious DiseasesCardiovascularOther
- Modalities
- Small moleculeTraditional Chinese medicine (herbal formulations)Biologic
- Industry
- Biotech
Drug pipeline
4 assets3 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Guangzhou Baiyunshan Qixing Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Guangzhou Baiyunshan Qixing Pharmaceutical.